Hepatitis C Treatments | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Hepatitis Treatments

What is…?

What is Mavyret? (glecaprevir and pibrentasvir)

What is Vosevi? (sofosbuvir, velpatasvir and voxilaprevir)

What is Zepatier? (elbasvir and grazoprevir)

What is Epclusa? (sofosbuvir/velpatasvir)

What is Daklinza? (daclatasvir)

What is Technivie? (ombitasvir, paritaprevir and ritonavir)

What is Viekira Pak™ (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets)?

What Is Harvoni® (ledipasvir and sofosbuvir)?

What is Ally-1? (daclatasvir, sofosbuvir and ribavirin)

What is Unity-1? (daclatasvir, asunaprevir, beclabuvir)

What is Olysio (simeprevir)?

What Is Sovaldi™ (sofosbuvir)?

What is Victrelis™ (boceprevir)? TO BE DISCONTINUED IN 2015

What is Incivek™ (telaprevir)? NO LONGER AVAILABLE

What is Rebetron?

What is Ribavirin

What is Interferon?

Learn about Hepatitis C treatments by genotype.

Older Articles and Clinical Studies

Ribavirin Treatment of HCV

Ribavirin approved for combo treatment

Ribavirin Interferon Combination with phlebotomy

Ribavirin Treatment alone or in combination with Interferon

IFN Alfa-2b Plus Ribavirin Combination Increases Sustained Response Rate

Phase III results of Interferon & Rebetol

FDA approves Rebetron Combination Therapy

Long term efficacy of Ribavirin plus interferon alfa

Interferon, Ribavirin and Actigall

Hepatitis C: Important Treatment Advance: Interview with Douglas Dieterich, MD

Schering Submits Supplemental NDA for REBETRON(TM)

New Therapy Packs Powerful One-Two Punch Against HCV

A randomized study comparing ribavirin and interferon alfa monotherapy for Hepatitis C recurrence after liver transplantation

Hepatitis C Virus Dynamics In Vivo: Effect of Ribavirin and Interferon Alfa on Viral Turnover

Effect of ribavirin on virus load and quasispecies distribution in patients infected with Hepatitis C virus

Treatment response in chronic Hepatitis C. Content of virus in serum is decisive for the outcome

Ribavirin monotherapy in patients with chronic Hepatitis C

Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic Hepatitis C not responding to interferon alone

Adding ribavirin to interferon alpha-2b for chronic Hepatitis C infection increased virological response and nausea

Ribavirin in Hepatitis C related cryoglobulinemia

Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic Hepatitis C patients

Ribavirin in Hepatitis C related cryoglobulinemia

Schering-Plough Reports Results of Clinical Studies of REBETRON(TM) Combination Therapy for Hepatitis C at American Association for the Study of Liver Diseases Meeting

Interferon alpha with ribavirin for the treatment of chronic Hepatitis C in non-responders or relapsers to interferon monotherapy

Hepatitis C Virus Dynamics In Vivo: Effect of Ribavirin and Interferon Alfa on Viral Turnover

Quantification of Serum Hepatitis C Virus RNA

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

Rebetron Safety Information

Warnings Placed On Rebetron Hepatitis Therapy


Learn about new research regarding Hepatitis C Treatments.